Details of the Drug

General Information of Drug (ID: DMLAYTP)

Drug Name
Soluble ferric pyrophosphate
Synonyms Ferric pyrophosphate; Soluble ferric pyrophosphate (anemia)
Indication
Disease Entry ICD 11 Status REF
Iron-deficiency anemia 3A00 Phase 3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski):
2		 Molecular Weight 745.21
Logarithm of the Partition Coefficient Not Available
Rotatable Bond Count 0
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 21
Chemical Identifiers
Formula
Fe4O21P6
IUPAC Name
iron(3+);phosphonato phosphate
Canonical SMILES
[O-]P(=O)([O-])OP(=O)([O-])[O-].[O-]P(=O)([O-])OP(=O)([O-])[O-].[O-]P(=O)([O-])OP(=O)([O-])[O-].[Fe+3].[Fe+3].[Fe+3].[Fe+3]
InChI
InChI=1S/4Fe.3H4O7P2/c;;;;3*1-8(2,3)7-9(4,5)6/h;;;;3*(H2,1,2,3)(H2,4,5,6)/q4*+3;;;/p-12
InChIKey
CADNYOZXMIKYPR-UHFFFAOYSA-B
Cross-matching ID
PubChem CID
24877
ChEBI ID
CHEBI:132767
CAS Number
10058-44-3
DrugBank ID
DB09147
TTD ID
D0Y2JM

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Iron (Fe) TTUDR0C NOUNIPROTAC Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Rockwell Medical Inc.
2 A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man. Br J Nutr. 2004 Jan;91(1):107-12.